Get started
Author

HansJörg Häuselmann

Observed names: H Hauselmann, H J Hauselmann, HJ Häuselmann, Hans-Jörg Haeuselmann, Hans-Jörg Häuselmann, Hansjorg J Häuselmann, Hansjörg Häuselmann, Hans‐Jörg Häuselmann, Hauselmann, H., Häuselmann HansJörg
ORCID: 0000-0002-6174-0980
Observed ORCID: 0000-0002-6174-0980
OpenAlex ID: A5109090492
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
2003 · K M Jordan, N K Arden, et al. · Annals of the Rheumatic Diseases · 2,066
PDF
Variation of cell and matrix morphologies in articular cartilage among locations in the adult human knee
2005 · Thomas M. Quinn, Ernst B. Hunziker, et al. · Osteoarthritis and Cartilage · 120
Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis
2020 · Judith Everts-Graber, Daniel Lehmann, et al. · Journal of Bone and Mineral Research · 115
PDF
Prediction of Hip Fracture Risk by Quantitative Ultrasound in More Than 7000 Swiss Women ≥70 Years of Age: Comparison of Three Technologically Different Bone Ultrasound Devices in the SEMOF Study
2006 · Marc-Antoine Krieg, Jacques Cornuz, et al. · Journal of Bone and Mineral Research · 102
PDF
Comparison of Three Bone Ultrasounds for the Discrimination of Subjects With and Without Osteoporotic Fractures Among 7562 Elderly Women
2003 · MA Krieg, J Cornuz, et al. · Journal of Bone and Mineral Research · 87
PDF
Phosphodiesterase isoenzyme families in human osteoarthritis chondrocytes – functional importance of phosphodiesterase 4
2002 · Hermann Tenor, Erik Hedbom, et al. · British Journal of Pharmacology · 47
PDF
Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting
2022 · Judith Everts-Graber, Stephan Reichenbach, et al. · Bone · 34
Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
2023 · Judith Everts-Graber, Harald Bonel, et al. · Osteoporosis International · 32
PDF
The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland
2024 · Judith Everts-Graber, Mathias Wenger, et al. · Osteoporosis International · 31
PDF
Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy—A Registry‐Based Cohort Study
2022 · Judith Everts‐Graber, Harald Bonel, et al. · JBMR Plus · 28
PDF
Level of acceptability of EULAR recommendations for the management of knee osteoarthritis by practitioners in different European countries
2005 · B Mazières, N Scmidely, et al. · Annals of the Rheumatic Diseases · 27
PDF
Does weight gain induce cortical and trabecular bone regain in anorexia nervosa? A two-year prospective study
2007 · Gabriella Milos, Anja Spindler, et al. · Bone · 23
Clinical Value of Prognostic Instruments to Identify Patients with an Increased Risk for Osteoporotic Fractures: Systematic Review
2011 · Johann Steurer, Cyrill Haller, et al. · PLoS ONE · 21
Are patterns of bone loss in anorexic and postmenopausal women similar? Preliminary results using high resolution peripheral computed tomography
2013 · Gabriella Milos, Hans-Jörg Häuselmann, et al. · Bone · 19
PDF
Bone Mineral Density in Young Women on Methadone Substitution
2011 · Gabriella Milos, Luigi M. Gallo, et al. · Calcified Tissue International · 18
PDF
Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey
2022 · Sigrid Jehle-Kunz, Hans-Jörg Häuselmann, et al. · Healthcare · 7
PDF
Long-term impact of teriparatide on bone mineral density, trabecular bone score, and fracture risk relative to total hip T-score: A two-decade, registry-based cohort study
2025 · Laura Guyer, Oliver Lehmann, et al. · Bone · 6
Empfehlungen der EULAR zur Behandlung der Gonarthrose Bericht einer Kommission des „Standing Committee for International Clinical Studies including Therapeutic Trials (ESCISIT)”
2002 · Pendleton, A., Arden, N., et al. · Zeitschrift für Rheumatologie · 5
Post-fracture care and predictors of anti-osteoporotic treatment in Switzerland: a nationwide health claims analysis
2026 · Judith Everts-Graber, Gernot Schmid, et al. · Osteoporosis International · 4
Cartilage proteins in serum and synovial fluid as markers for cartilage degradation
1995 · Michel Neidhart, Nik Hauser, et al. · Acta Orthopaedica Scandinavica · 4
PDF
Impact of FRAXplus adjustments vs FRAX on fracture risk classification in the Swiss Osteoporosis Registry
2026 · Carla Martignoni, Oliver Lehmann, et al. · JBMR Plus · 2
Fracture risk prediction in postmenopausal women with traditional and machine learning models in a nationwide, prospective cohort study in Switzerland with validation in the UK Biobank
2024 · Oliver Lehmann, Olga Mineeva, et al. · Journal of Bone and Mineral Research · 2
Bilateral osteonecrosis of the talus and “standing obsession” in a patient with anorexia nervosa
2001 · Gabriella Milos, Jürg Willi, et al. · International Journal of Eating Disorders · 2
Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
2023 · Judith Everts-Graber, Harald Bonel, et al. · Osteoporosis International · 1
PDF
Author response for "Risk of Osteonecrosis of the Jaw under Denosumab Compared to Bisphosphonates in Patients with Osteoporosis"
2021 · Everts‐Graber Judith, Lehmann Daniel, et al. · Publons reviews and discussion · 1
Works count: 31
Citation count: 2,804
H-index: 15
I10-index: 15
Year
Topic
Type